DNAVision Overview

  • Founded
  • 2004

  • Status
  • Private

  • Employees
  • 16

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

DNAVision General Information


Provider of genomic services intended to serve the pharmaceutical, food, and biotechnology industries. The company uses state-of-the-art instrumentation and methods validated in a quality environment to offer various application notes arising from scientific expertise in the characterization of genetic polymorphic markers, thereby providing clients with analytical services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 25 Avenue Georges Lemaitre
  • 6041 Charleroi
  • Belgium
+32 071 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNAVision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 00.000 Completed Generating Revenue
2. Later Stage VC 03-Jan-2013 00.000 00.000 00.000 Completed Generating Revenue
1. Early Stage VC 29-Apr-2006 $1M $1M Completed Generating Revenue
To view DNAVision’s complete valuation and funding history, request access »

DNAVision Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pref 00,000 000.0 000.0 00 000.0 000
To view DNAVision’s complete cap table history, request access »

DNAVision Executive Team (3)

Name Title Board Seat Contact Info
Laurent Alexandre President
Patricia Lienard Chief Operating Officer
You’re viewing 2 of 3 executive team members. Get the full list »

DNAVision Board Members (2)

Name Representing Role Since
Jean-Claude Havaux Self Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

DNAVision Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNAVision Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bio.be Corporation Minority 000 0000 000000 0
Université Libre de Bruxelles University Minority 000 0000 000000 0
To view DNAVision’s complete investors history, request access »